AtriCure Net Debt from 2010 to 2024

ATRC Stock

USD 36.01 0.27 0.76%

AtriCure's Net Debt is increasing over the years with slightly volatile fluctuation. Overall, Net Debt is projected to go to about -9.3 M this year. Net Debt is the total debt of AtriCure minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2004-12-31

Previous Quarter

-30.7 M

Current Value

-53.2 M

Quarterly Volatility

23.6 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check AtriCure financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AtriCure's main balance sheet or income statement drivers, such as Interest Expense of 7.3 M, Total Revenue of 419.2 M or Gross Profit of 315.4 M, as well as many indicators such as Price To Sales Ratio of 3.93, Dividend Yield of 0.0 or PTB Ratio of 3.76. AtriCure financial statements analysis is a perfect complement when working with AtriCure Valuation or Volatility modules.

Check out the analysis of AtriCure Correlation against competitors.

For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.

Latest AtriCure's Net Debt Growth Pattern

Below is the plot of the Net Debt of AtriCure over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. AtriCure's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AtriCure's overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

AtriCure Net Debt Regression Statistics

	Arithmetic Mean	6,946,290
	Coefficient Of Variation	287.70
	Mean Deviation	16,649,196
	Median	683,000
	Standard Deviation	19,984,818
	Sample Variance	399.4T
	Range	72.3M
	R-Value	0.35
	Mean Square Error	378.2T
	R-Squared	0.12
	Significance	0.20
	Slope	1,552,834
	Total Sum of Squares	5591.5T

AtriCure Net Debt History

	2024	-9.3 M
	2023	-9.8 M
	2022	11 M
	2021	32 M
	2020	32.1 M
	2019	47.9 M
	2018	20.2 M

Other Fundumenentals of AtriCure

Net Debt To E B I T D A

AtriCure Net Debt component correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Total Liab	Accounts Payable	Common Stock	Property Plant Equipment	Net Debt	Net Receivables	Total Current Assets	Long Term Debt	Good Will	Short Term Investments	Short Term Debt	Intangible Assets	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Long Term Investments	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.96	-0.95	0.77	0.84	0.85	0.88	0.5	0.83	0.94	0.96	0.98	0.71	0.42	0.73	-0.32	0.5	0.88	0.92	0.37	0.4	0.89	0.86	0.82
Total Stockholder Equity	0.96		-0.93	0.57	0.89	0.81	0.9	0.32	0.9	0.94	0.93	0.95	0.61	0.34	0.52	-0.3	0.72	0.83	0.92	0.46	0.37	0.94	0.84	0.91
Retained Earnings	-0.95	-0.93		-0.71	-0.88	-0.89	-0.91	-0.43	-0.89	-0.93	-0.94	-0.94	-0.62	-0.42	-0.67	0.51	-0.52	-0.88	-0.9	-0.25	-0.34	-0.84	-0.81	-0.79
Total Liab	0.77	0.57	-0.71		0.41	0.72	0.54	0.78	0.39	0.64	0.73	0.72	0.73	0.48	0.98	-0.29	-0.13	0.78	0.68	0.15	0.38	0.53	0.64	0.36
Accounts Payable	0.84	0.89	-0.88	0.41		0.69	0.93	0.09	0.98	0.81	0.85	0.9	0.28	0.08	0.39	-0.39	0.68	0.7	0.78	0.2	0.26	0.79	0.64	0.86
Common Stock	0.85	0.81	-0.89	0.72	0.69		0.79	0.5	0.69	0.76	0.79	0.79	0.62	0.42	0.68	-0.55	0.4	0.87	0.91	0.4	0.4	0.72	0.67	0.57
Property Plant Equipment	0.88	0.9	-0.91	0.54	0.93	0.79		0.27	0.93	0.81	0.88	0.92	0.37	0.11	0.55	-0.33	0.57	0.81	0.83	0.22	0.42	0.75	0.64	0.76
Net Debt	0.5	0.32	-0.43	0.78	0.09	0.5	0.27		0.09	0.31	0.55	0.44	0.54	0.25	0.73	-0.21	-0.28	0.68	0.44	0.41	0.1	0.33	0.35	0.08
Net Receivables	0.83	0.9	-0.89	0.39	0.98	0.69	0.93	0.09		0.83	0.86	0.89	0.3	0.15	0.36	-0.34	0.72	0.72	0.79	0.19	0.21	0.8	0.67	0.87
Total Current Assets	0.94	0.94	-0.93	0.64	0.81	0.76	0.81	0.31	0.83		0.89	0.91	0.77	0.59	0.6	-0.3	0.63	0.78	0.88	0.24	0.36	0.9	0.95	0.87
Long Term Debt	0.96	0.93	-0.94	0.73	0.85	0.79	0.88	0.55	0.86	0.89		0.97	0.6	0.3	0.67	-0.32	0.49	0.92	0.89	0.39	0.26	0.89	0.81	0.82
Good Will	0.98	0.95	-0.94	0.72	0.9	0.79	0.92	0.44	0.89	0.91	0.97		0.57	0.27	0.68	-0.29	0.52	0.87	0.9	0.33	0.35	0.88	0.8	0.85
Short Term Investments	0.71	0.61	-0.62	0.73	0.28	0.62	0.37	0.54	0.3	0.77	0.6	0.57		0.84	0.69	-0.18	0.23	0.61	0.67	0.27	0.4	0.64	0.87	0.47
Short Term Debt	0.42	0.34	-0.42	0.48	0.08	0.42	0.11	0.25	0.15	0.59	0.3	0.27	0.84		0.44	-0.24	0.15	0.3	0.38	-0.01	0.18	0.36	0.66	0.23
Intangible Assets	0.73	0.52	-0.67	0.98	0.39	0.68	0.55	0.73	0.36	0.6	0.67	0.68	0.69	0.44		-0.24	-0.18	0.73	0.63	0.02	0.46	0.44	0.59	0.28
Current Deferred Revenue	-0.32	-0.3	0.51	-0.29	-0.39	-0.55	-0.33	-0.21	-0.34	-0.3	-0.32	-0.29	-0.18	-0.24	-0.24		-0.12	-0.31	-0.3	-0.08	-0.18	-0.22	-0.22	-0.19
Net Tangible Assets	0.5	0.72	-0.52	-0.13	0.68	0.4	0.57	-0.28	0.72	0.63	0.49	0.52	0.23	0.15	-0.18	-0.12		0.35	0.58	0.43	0.09	0.73	0.56	0.81
Long Term Debt Total	0.88	0.83	-0.88	0.78	0.7	0.87	0.81	0.68	0.72	0.78	0.92	0.87	0.61	0.3	0.73	-0.31	0.35		0.92	0.4	0.24	0.8	0.74	0.65
Capital Surpluse	0.92	0.92	-0.9	0.68	0.78	0.91	0.83	0.44	0.79	0.88	0.89	0.9	0.67	0.38	0.63	-0.3	0.58	0.92		0.46	0.36	0.91	0.84	0.8
Long Term Investments	0.37	0.46	-0.25	0.15	0.2	0.4	0.22	0.41	0.19	0.24	0.39	0.33	0.27	-0.01	0.02	-0.08	0.43	0.4	0.46		0.03	0.55	0.25	0.38
Short Long Term Debt	0.4	0.37	-0.34	0.38	0.26	0.4	0.42	0.1	0.21	0.36	0.26	0.35	0.4	0.18	0.46	-0.18	0.09	0.24	0.36	0.03		0.23	0.37	0.19
Net Invested Capital	0.89	0.94	-0.84	0.53	0.79	0.72	0.75	0.33	0.8	0.9	0.89	0.88	0.64	0.36	0.44	-0.22	0.73	0.8	0.91	0.55	0.23		0.88	0.94
Net Working Capital	0.86	0.84	-0.81	0.64	0.64	0.67	0.64	0.35	0.67	0.95	0.81	0.8	0.87	0.66	0.59	-0.22	0.56	0.74	0.84	0.25	0.37	0.88		0.82
Capital Stock	0.82	0.91	-0.79	0.36	0.86	0.57	0.76	0.08	0.87	0.87	0.82	0.85	0.47	0.23	0.28	-0.19	0.81	0.65	0.8	0.38	0.19	0.94	0.82

Click cells to compare fundamentals

About AtriCure Financial Statements

AtriCure stakeholders use historical fundamental indicators, such as AtriCure's Net Debt, to determine how well the company is positioned to perform in the future. Although AtriCure investors may analyze each financial statement separately, they are all interrelated. For example, changes in AtriCure's assets and liabilities are reflected in the revenues and expenses on AtriCure's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in AtriCure. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Net Debt	-9.8 M	-9.3 M
Net Debt To EBITDA	1.21	1.27

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

When determining whether AtriCure offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AtriCure's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atricure Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atricure Stock:

How To Invest In AtriCure

Details

Is AtriCure Stock a good investment?

Details

What is AtriCure's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of AtriCure Correlation against competitors.

For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.

You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AtriCure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.83)

Revenue Per Share

9.564

Quarterly Revenue Growth

0.179

Return On Assets

(0.04)

Return On Equity

(0.08)

The market value of AtriCure is measured differently than its book value, which is the value of AtriCure that is recorded on the company's balance sheet. Investors also form their own opinion of AtriCure's value that differs from its market value or its book value, called intrinsic value, which is AtriCure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AtriCure's market value can be influenced by many factors that don't directly affect AtriCure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between AtriCure's value and its price as these two are different measures arrived at by different means. Investors typically determine if AtriCure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AtriCure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

AtriCure Net Debt from 2010 to 2024

Latest AtriCure's Net Debt Growth Pattern

AtriCure Net Debt Regression Statistics

AtriCure Net Debt History

Other Fundumenentals of AtriCure

AtriCure Net Debt component correlations

About AtriCure Financial Statements

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY